RHHBY news

Latest 3 stories · newest Sep 24, 2026

RHHBY
Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine
RHHBY
Why Is BioNTech Stock Surging on Wednesday?
RHHBY
Nurix partners with Roche on BTK degrader bexobrutideg for up to $2.3B

Nurix Therapeutics announced a global collaboration with Roche to co-develop and co-commercialize bexobrutideg, receiving $700 million upfront plus up to $2.3 billion in milestone payments. The partnership combines Nurix's protein degradation technology with Roche's clinical expertise to expand bexo…

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same RHHBY feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/RHHBY/newsSTART FREE